MTAC — MedTech Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsBalancedSmall CapNeutral
- $320.31m
- $320.80m
- 41
- 44
- 60
- 48
Annual cashflow statement for MedTech Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K/A | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.711 | 4.77 |
| Non-Cash Items | 0.604 | -7.81 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.57 | 1.3 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -0.678 | -1.74 |
| Other Investing Cash Flow Items | -250 | 0.06 |
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -250 | 0.06 |
| Financing Cash Flow Items | -0.412 | 0.544 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 252 | 0.544 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 1.33 | -1.13 |